Efficacy and tolerability of tadalafil for treatment of erectile dysfunction in men taking serotonin reuptake inhibitors

Urology

Volumn 77, Issue 5, 2011, Pages 1137-1141

  Evliyaoǧlu, Yalçin ^a,b,c,d   Yelsel, Kazim ^a,b,c,d   Kobaner, Murat ^a,b,c,d   Alma, Ergün ^a,b,c,d   Saygili, Melike ^a,b,c,d  

^a ADANA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^b Viransehir State Hospital   (Turkey)

^c Urology Section   (Turkey)

^d Ceyhan State Hospital   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; CLOMIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; PAROXETINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TADALAFIL; VENLAFAXINE;

ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BACKACHE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG TOLERABILITY; DYSPEPSIA; ELECTROCARDIOGRAPHY; ERECTILE DYSFUNCTION; FLUSHING; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLOBAL ASSESSMENT QUESTIONS; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LABORATORY TEST; MALE; MYALGIA; ORGASM; PATIENT SATISFACTION; PENIS ERECTION; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SEXUAL ENCOUNTER PROFILE; SEXUAL FUNCTION; SEXUAL SATISFACTION; SIDE EFFECT; TREATMENT RESPONSE; VISUAL DISORDER; VITAL SIGN;

ADULT; AGED; CARBOLINES; DOUBLE-BLIND METHOD; ERECTILE DYSFUNCTION; HUMANS; MALE; MIDDLE AGED; PHOSPHODIESTERASE 5 INHIBITORS; PROSPECTIVE STUDIES; SEROTONIN UPTAKE INHIBITORS; YOUNG ADULT;

EID: 79955584246     PISSN: 00904295     EISSN: 15279995     Source Type: Journal    
DOI: 10.1016/j.urology.2010.12.036     Document Type: Article

References (11)

1. Mathew RJ, Weinman ML. Sexual dysfunctions in depression. Arch Sex Behav. 1982;11:323-328. (Pubitemid 13248990)
2. Araujo AB, Durante R, Feldman HA, et al. The relationship between depressive symptoms and male erectile dysfunction: crosssectional results from the Massachusetts Male aging Study. Psychosom Med. 1998;60:458-465. (Pubitemid 28354846)
3. Casper RC, Redmond DE, Katz MM, et al. Somatic symptoms in primary affective disorders: presence and relationship to the classification of depression. Arch Gen Psychiatry. 1985;42:1098-1104.
4. Padma-Nathan H, McMurray JG, Pullman WE, et al. On-demand IC 351 enhances erectile function in patients with erectile dysfunction. Int J Impot Res. 2001;13:2-9. (Pubitemid 32274643)
5. Porst H, Padma-Nathan H, Giuliano F, et al. Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology. 2003;62:121-126. (Pubitemid 36802084)
6. Porst H, Giuliano F, Glina S, et al. Evaluation of the efficacy and safety of once-a-day dosing of tadalafil 5 mg and 10 mg in the treatment of erectile dysfunction: results of a multicenter, randomized, double-blind, placebo-controlled trial. Eur Urol. 2006;50:351-359. (Pubitemid 44038075)
7. Yip WC, Chiang HS, Mendoza JB, et al. Efficacy and safety of on-demand tadalafil in the treatment of East and Southern Asian men with erectile dysfunction: a randomized, double-blind, parallel, placebo-controlled clinical study. Asian J Androl. 2006;8:685-692. (Pubitemid 44869616)
8. Şaylan M, Khalaf I, Kadioǧlu A, et al. Efficacy of tadalafil in Egyptian and Turkish men with erectile dysfunction. Int J Clin Pract. 2006;60:812-819. (Pubitemid 43881155)
9. Greden J. The burden of disease for treatment-resistant depression. J Clin Psychiatry. 2001;62:26-31.
10. Montorsi F, Verheyden B, Meuleman E, et al. Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction. Eur Urol. 2004;45:339-345. (Pubitemid 38221407)
11. Brock G, McMahon CG, Chen KK, et al. Efficacy and safety of tadalafil in the treatment of erectile function: results of integrated analyses. J Urol. 2002;168:1332-1336. (Pubitemid 35034115)